P
US5886192AExpiredUtilityPatentIndex 61

L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1!heptane compounds

Assignee: RHONE POULENC RORER SAPriority: May 30, 1995Filed: Jun 10, 1997Granted: Mar 23, 1999
Est. expiryMay 30, 2015(expired)· nominal 20-yr term from priority
Inventors:LEON PATRICKLARGEAU DENISDURAND THIERRYO'BRIEN MICHAELPOWERS MATTHEW
Y02P20/55C07D 209/02C07D 209/52C07D 491/18
61
PatentIndex Score
3
Cited by
8
References
3
Claims

Abstract

A method for the preparation of a lactam compound of formula ##STR1## wherein R' 1 and R" 1 independently are acyl or aroyl, or taken together form an optionally substituted methylene, and G 1 is hydrogen or an amino protecting group, comprising oxidizing a bis O-protected 1R-2-azadihydroxybicyclo- 2.2.1!heptane compound of formula ##STR2## with about 0.1 mol % to about 1 mol % of RuO 2 or hydrate thereof in the presence of about 3 equivalents of an oxidant to form the lactam compound with an enantiomeric excess of greater than or equal to about 95%.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. A method for the preparation of a lactam compound of formula ##STR22## wherein R' 1  and R" 1  independently are acyl or aroyl, or taken together form an optionally substituted methylene, and G 1  is hydrogen or an amino protecting group, comprising oxidizing a bis O-protected 1R-2-azadihydroxybicyclo- 2.2.1!heptane compound of formula ##STR23## with about 0.1 mol % to about 1 mol % of RuO 2  or hydrate thereof in the presence of about 3 equivalents of an oxidant to form the lactam compound with an enantiomeric excess of greater than or equal to about 95%. 
     
     
       2. The method according to claim 1 wherein RuO 2  is present at about 0.5 mol %. 
     
     
       3. The method according to claim 1 wherein the lactam compound is formed with an enantiomeric excess of greater than or equal to about 99%.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.